Q-Line Biotech IPO
Open SmeCurrent GMP
₹112 (+32.65%)
Price Band
₹ 326 – 343
Lot Size
400
Issue Size
₹214 Cr
Minimum Investment
₹274400 (800 Shares)
Listing Date
29 May 2026
Subscription
102.49x
About the Company
Promoters
- Saurabh Garg
- Amita Garg
- Ayush Garg
- Ajay Kumar Mahanty
- Abhay Agrawal
Promoters Holding
Holding Pre Issue
96.77%
Holding Post Issue
67.51%
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.
- To meet Working Capital requirements
- Repayment of certain borrowing availed by our Company, in part or full
- General Corporate Purpose
Address / Contact Info
Q-Line Biotech Limited
298-281, Transport Nagar,
Kanpur Road Adjacent Transport Nagar Metro Station
Lucknow, Uttar Pradesh, 226012
Email:compliance@qlinebiotech.com
Telephone: +91 522-2435570
Website:https://qlinebiotech.com/
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Thursday, 21 May 2026
IPO Close Date
Monday, 25 May 2026
Basis of Allotment
Tuesday, 26 May 2026
Initiation of Refunds
Wednesday, 27 May 2026
Credit of Shares to Demat
Wednesday, 27 May 2026
Listing Date
Friday, 29 May 2026 — NSE & BSE
Important Dates
Open Date
21 May 2026
Close Date
25 May 2026
Basis Of Allotment
26 May 2026
Listing Date
29 May 2026
Financial Performance (₹ in Crores)
| Particular | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 561.34 | 455.49 | 339.25 | 251.58 |
| Revenue | 236.5 | 322.58 | 206.45 | 184.81 |
| Profit After Tax | 38.69 | 28.13 | 34.44 | 32.1 |
| Net Worth | -0.04 | 189.95 | 161.81 | 127.37 |
| Reserve & Surplus | 21288920 | 188.37 | 160.24 | 125.79 |
| Total Borrowings | 243.85 | 164.95 | 96.91 | 73.65 |
EPS Pre
16.47%
EPS Post
22.12%
P/E Pre
20.82
P/E (Post Issue)
15.51x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | Dec 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| ROE % | 16.88 | 17.66 | 19.25 | 22.14 |
| ROCE % | 13.32 | 23.74 | 21.29 | 25.2 |
| Debt / Equity | 1.06 | 0.87 | 0.6 | 0.58 |
| RoNW % | 16.88 | 23.74 | 21.29 | 25.2 |
| PbW | 0 | 0 | 0 | 0 |
| Pat Margin % | 16.65 | 8.97 | 16.92 | 17.56 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 1188000 | 28.57 | 0 |
| Non-Institutional | 891600 | 21.44 | 0 |
| BNII | 594400 | 14.29 | 0 |
| SNII | 297200 | 7.15 | 0 |
| Retail Investors | 2079200 | 50 | 0 |
| Total | 4158800 | 100 | 0 |
Subscription Status ( Mon, 25 May 26 01:42 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 1188000 | 147237200 | 123.94x |
| Non-Institutional | 891600 | 130466800 | 146.33x |
| BNII | 594400 | 106289200 | 178.82x |
| SNII | 297200 | 24177600 | 81.35x |
| Retail Investors | 2079200 | 148541600 | 71.44x |
| Total | 4158800 | 426245600 | 102.49x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
No Peer Comparision Available
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 800 | 274,400.00 |
| Retail (Max) | 2 | 800 | 274,400.00 |
| S-HNI (Min) | 3 | 1,200 | 411,600.00 |
| S-HNI (Max) | 7 | 2,800 | 960,400.00 |
| B-HNI (Min) | 8 | 3,200 | 1,097,600.00 |
Registrar
Purva Sharegistry India Pvt Ltd
91 22 3522 0056 , 91 22 4961 4132
support@purvashare.com
https://www.purvashare.com
Book Running Lead Managers
- Hem Securities Limited
- Share India Capital Services Private Limited
RHP Document
DRHP Document
Anchor Investors
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Q-Line Biotech IPO is a Book-building IPO worth ₹214 crores. The price band is ₹326 to 343 per share. The IPO opens on Thu, May 21, 2026 and closes on Mon, May 25, 2026. It will be listed on BSE and NSE. Purva Sharegistry India Pvt Ltd is the registrar.
The Q-Line Biotech IPO opens on Thu, May 21, 2026 and closes on Mon, May 25, 2026
Q-Line Biotech IPO Price Band is ₹326 to 343.
Q-Line Biotech IPO lot size is 400, and the minimum amount required for application is ₹274400.
The minimum investment for Q-Line Biotech IPO is approximately ₹274400 based on the upper price band.
To apply for the Q-Line Biotech IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Mon, May 25, 2026. After submission, funds are blocked until the basis of allotment of Q-Line Biotech IPO is finalised.
Q-Line Biotech IPO issue size is ₹214 crores.
Q-Line Biotech IPO allotment date is Sat, Jun 27, 2026.
The registrar for Q-Line Biotech IPO is Purva Sharegistry India Pvt Ltd. Investors can go to Purva Sharegistry India Pvt Ltd website for IPO allotment status, refund processing, and other queries related to Q-Line Biotech IPO through their official website or helpline.
The Q-Line Biotech IPO GMP (Grey Market Premium) is ₹112 as of Fri, May 29, 2026. Based on the upper price band of ₹343 per share, the estimated Q-Line Biotech IPO listing price is ₹455, indicating a potential listing gain of approximately 31% over the issue price.